121
122
123
124
Coene, K.L.M., Dekker, M.J.E., Kerskes, M.C.H.M., Hengst, M., Schonck, M.J.M., Konings, C.J.A.M., Scharnhorst, V.
Veröffentlicht in: Coene , K L M , Dekker , M J E , Kerskes , M C H M , Hengst , M , Schonck , M J M , Konings , C J A M & Scharnhorst , V 2017 , ' Practical value of anti-xa activity in the evaluation of extracorporeal circuit anticoagulation during haemodialysis : Results of a cross-sectional single-centre study ' , Nephron , vol. 137 , no. 3 , pp. 205-211 . https://doi.org/10.1159/000479390;
2017
Veröffentlicht in: Coene , K L M , Dekker , M J E , Kerskes , M C H M , Hengst , M , Schonck , M J M , Konings , C J A M & Scharnhorst , V 2017 , ' Practical value of anti-xa activity in the evaluation of extracorporeal circuit anticoagulation during haemodialysis : Results of a cross-sectional single-centre study ' , Nephron , vol. 137 , no. 3 , pp. 205-211 . https://doi.org/10.1159/000479390;
2017
125
126
127
Li, Xuechun, Bijlsma, Maarten J, Bos, Jens H J, Schuiling-Veninga, Catharina C M, Hak, Eelko
Veröffentlicht in: Li , X , Bijlsma , M J , Bos , J H J , Schuiling-Veninga , C C M & Hak , E 2023 , ' Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events : A population-based retrospective inception cohort study in the Netherlands ' , BMJ Open , vol. 13 , no. 8 , e068721 . https://doi.org/10.1136/bmjopen-2022-068721;
2023
Veröffentlicht in: Li , X , Bijlsma , M J , Bos , J H J , Schuiling-Veninga , C C M & Hak , E 2023 , ' Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events : A population-based retrospective inception cohort study in the Netherlands ' , BMJ Open , vol. 13 , no. 8 , e068721 . https://doi.org/10.1136/bmjopen-2022-068721;
2023
128
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
129
130
Macdonald, Thomas M, Hawkey, Chris J, Ford, Ian, McMurray, John J V, Scheiman, James M, Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E, Hobbs, F D Richard, Ralston, Stuart H, Reid, David M, Walters, Matthew R, Webster, John, Ruschitzka, Frank, Ritchie, Lewis D, Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S
Veröffentlicht in: Macdonald , T M , Hawkey , C J , Ford , I , McMurray , J J V , Scheiman , J M , Hallas , J , Findlay , E , Grobbee , D E , Hobbs , F D R , Ralston , S H , Reid , D M , Walters , M R , Webster , J , Ruschitzka , F , Ritchie , L D , Perez-Gutthann , S , Connolly , E , Greenlaw , N , Wilson , A , Wei , L & Mackenzie , I S 2017 , ' Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib : the Standard care vs. Celecoxib Outcome Trial (SCOT) ' , European Heart Journal , vol. 38 , no. 23 , pp. 1843-1850 . https://doi.org/10.1093/eurheartj/ehw387;
2017
Veröffentlicht in: Macdonald , T M , Hawkey , C J , Ford , I , McMurray , J J V , Scheiman , J M , Hallas , J , Findlay , E , Grobbee , D E , Hobbs , F D R , Ralston , S H , Reid , D M , Walters , M R , Webster , J , Ruschitzka , F , Ritchie , L D , Perez-Gutthann , S , Connolly , E , Greenlaw , N , Wilson , A , Wei , L & Mackenzie , I S 2017 , ' Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib : the Standard care vs. Celecoxib Outcome Trial (SCOT) ' , European Heart Journal , vol. 38 , no. 23 , pp. 1843-1850 . https://doi.org/10.1093/eurheartj/ehw387;
2017